Author: Darren Burgess - Page 2

Therapeutic Equivalence: Are Authorized Generics Really the Same as Brand Drugs?

Authorized generics are identical to brand-name drugs in every way - same ingredients, same manufacturer, same quality. Learn how they compare, why they’re not listed in the Orange Book, and when they’re the best choice for patients.

How to Appeal Insurance Denials for Brand-Name Medications

Learn how to successfully appeal an insurance denial for brand-name medications with step-by-step guidance, critical documentation tips, and real success rates from internal and external reviews.

Cost Comparison: Authorized Generics vs First-to-File Generics - What You Really Pay

Authorized generics and first-to-file generics both lower drug costs, but authorized generics drive prices down faster and deeper. Learn how they differ, why prices drop more when both are on the market, and what it means for your prescription costs.

Chronic Pain Conditions: Effective Ways to Manage Lifelong Pain

Chronic pain lasts beyond healing time and affects millions. Learn evidence-based, non-opioid strategies like exercise, CBT, and multidisciplinary rehab that actually improve function and quality of life - backed by CDC, WHO, and Mayo Clinic research.

How to Read Prescription Label Directions Like BID, TID, and PRN

Learn how to read common prescription abbreviations like BID, TID, and PRN to take your meds safely and correctly. Understand timing, avoid errors, and know what to ask your pharmacist.

Azathioprine and Allopurinol: How the Combination Prevents Toxic Metabolite Buildup

LDAA therapy combines low-dose azathioprine with allopurinol to redirect toxic metabolite buildup in IBD patients. It’s effective for those with high TPMT activity and liver damage from standard therapy - but only with strict dosing and monitoring.

Quality by Design in Generic Drug Development: Modern Science-Based Approaches

Quality by Design (QbD) is now the standard for generic drug development, replacing outdated testing methods with science-based process control. Learn how QbD improves bioequivalence, cuts approval times, and saves millions-while ensuring every generic pill works as intended.

Patient Counseling on Generics: What Pharmacists Must Discuss to Ensure Adherence and Trust

Pharmacists must clearly explain generic substitutions to patients to prevent misunderstandings, improve adherence, and ensure safety. Learn the key counseling points, legal requirements, and practical strategies to build trust and reduce non-adherence.

How the FDA Monitors Drug Safety After Medication Approval

The FDA uses a mix of reporting systems, real-time data analysis, and strict regulations to monitor drug safety after approval. Learn how FAERS, Sentinel, and REMS work together to catch hidden risks and protect patients.

Red Flags: When to Call Your Doctor About a Medication Problem

Learn the red flags that mean you need to call your doctor right away about a medication problem. Know when side effects are harmless-and when they’re life-threatening.